Chronic Plaque Psoriasis Market Report 2026
Download Free Sample Buy Now
Chronic Plaque Psoriasis Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Chronic Plaque Psoriasis Market Report 2026

Global Outlook – By Drug Class (Biologics, Small Molecule Drugs), By Route Of Administration (Injectable, Oral, Topical), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Chronic Plaque Psoriasis Market Overview

• Chronic Plaque Psoriasis market size has reached to $22.26 billion in 2025

• Expected to grow to $30.99 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%

• Growth Driver: Impact Of Immune System Dysfunction On Chronic Plaque Psoriasis Treatment Demand

• Market Trend: Advancements In IL-17A And IL-17F Inhibitor Therapies For Plaque Psoriasis Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Chronic Plaque Psoriasis Market?

Chronic plaque psoriasis is a persistent, inflammatory skin condition characterized by the formation of well-defined, raised, red patches covered with silvery-white scales. These plaques most commonly appear on the scalp, elbows, knees, and lower back but can occur anywhere on the body. It is an autoimmune disorder in which the immune system triggers an accelerated turnover of skin cells, leading to their buildup on the surface.

The main drug classes of chronic plaque psoriasis are biologics and small-molecule drugs. Biologics are advanced medications derived from living organisms that target specific components of the immune system to treat various diseases. It is available as injectables, oral, and topical and is distributed through hospital pharmacies, online pharmacies, and retail pharmacies.

Chronic Plaque Psoriasis Market Global Report 2026 Market Report bar graph

What Is The Chronic Plaque Psoriasis Market Size and Share 2026?

The chronic plaque psoriasis market size has grown strongly in recent years. It will grow from $22.26 billion in 2025 to $23.83 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to improved diagnosis of autoimmune skin disorders, wider availability of topical therapies, increased awareness of psoriasis management, expansion of dermatology clinics, improved access to specialty drugs.

What Is The Chronic Plaque Psoriasis Market Growth Forecast?

The chronic plaque psoriasis market size is expected to see strong growth in the next few years. It will grow to $30.99 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing development of next-generation biologics, rising adoption of oral immunomodulators, expansion of precision dermatology approaches, growing focus on patient-centric treatment plans, increasing investment in autoimmune disease research. Major trends in the forecast period include increasing adoption of biologic therapies, rising use of targeted small molecule drugs, growing focus on personalized dermatology care, expansion of oral treatment options, enhanced emphasis on long-term disease control.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Chronic Plaque Psoriasis Market Segmentation

1) By Drug Class: Biologics, Small Molecule Drugs

2) By Route Of Administration: Injectable, Oral, Topical

3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors (IL-12, IL-23, IL-17, IL-22), T-Cell Inhibitors

2) By Small Molecule Drugs: Phosphodiesterase 4 (PDE4) Inhibitors, Janus Kinase (JAK) Inhibitors, Retinoids

What Is The Driver Of The Chronic Plaque Psoriasis Market?

The increasing cases of immune system dysfunction are expected to propel the growth of the chronic plaque psoriasis market going forward. Immune system dysfunction refers to a state where the immune system fails to operate effectively, leading to increased susceptibility to infections, autoimmune diseases, and cancer. The increasing cases of immune system dysfunction are attributed to factors such as genetic predispositions, environmental triggers, malnutrition, chronic stress, and the rising prevalence of autoimmune diseases and infections like HIV. Chronic plaque psoriasis treatment is required to regulate immune system dysfunction, as the immune system mistakenly triggers an overproduction of skin cells, leading to inflammation and the formation of plaques. For instance, in February 2024 according to the Arthritis Australia is a Australia-based non-profit organization In 2025, an estimated 212,136 males and 362,137 females are projected to have rheumatoid arthritis (RA), with the numbers expected to rise by 2040 to approximately 280,040 males and 479,828 females. Therefore, the increasing cases of immune system dysfunction are driving the growth of the chronic plaque psoriasis industry.

Key Players In The Global Chronic Plaque Psoriasis Market

Major companies operating in the chronic plaque psoriasis market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Amgen Inc., Dr Reddy’s Laboratories, Innovent Biologics Inc., Bio-Thera Solutions, Celgene Corporation, Arcutis Biotherapeutics, LEO Pharma A/S, Sun Pharmaceutical Industries Ltd, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Biocon Ltd, Stiefel Laboratories Inc, Regeneron Pharmaceuticals, Sanofi S.A., GSK plc, Merck & Co. Inc., UCB S.A., Roche Holding AG, Evelo Biosciences Inc, Biogen Inc.

Global Chronic Plaque Psoriasis Market Trends and Insights

Major companies operating in the chronic plaque psoriasis market are focusing on developing innovative treatments, such as IL-17A and IL-17F inhibitors, to gain advancement in the treatment of chronic plaque psoriasis. IL-17A and IL-17F inhibitors are targeted biologic therapies that block interleukin-17A and interleukin-17F, pro-inflammatory cytokines involved in the immune response, to reduce inflammation in autoimmune diseases like chronic plaque psoriasis. For instance, in October 2023, UCB S.A., a Belgium-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved BIMZELX (bimekizumab-bkzx) for adults with moderate to severe plaque psoriasis who are eligible for systemic therapy or phototherapy. Bimekizumab is the first approved medication for psoriasis specifically designed to target and inhibit interleukin 17A (IL-17A) and interleukin 17F (IL-17F), two key cytokines involved in inflammatory processes. Its approval was based on evidence from three Phase 3 multicenter trials BE READY, BE VIVID, and BE SURE which collectively assessed its safety and efficacy in 1,480 patients with moderate to severe plaque psoriasis.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Chronic Plaque Psoriasis Market?

In October 2024, Organon, a US-based healthcare company, acquired Dermavant Sciences Ltd. for an undisclosed amount. This acquisition enhances Organon’s dermatology portfolio with the addition of VTAMA (tapinarof) Cream, 1%, an innovative dermatologic therapy. VTAMA Cream is a novel, nonbiologic, non-steroidal topical treatment approved by the U.S. Food and Drug Administration (FDA) for managing mild, moderate, and severe plaque psoriasis in adults. Dermavant Sciences Ltd. is a US-based company focused on developing and commercializing innovative therapies in the field of immunodermatology.

Regional Outlook

North America was the largest region in the chronic plaque psoriasis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Chronic Plaque Psoriasis Market?

The chronic plaque psoriasis market consists of revenues earned by entities by providing services such as medication delivery services, customized treatment plans, and genetic and biomarker testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic plaque psoriasis market also includes sales of vitamin D analogues, combination topicals, phosphodiesterase-4 inhibitors, and janus kinase inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Chronic Plaque Psoriasis Market Report 2026?

The chronic plaque psoriasis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the chronic plaque psoriasis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Chronic Plaque Psoriasis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $23.83 billion
Revenue Forecast In 2035 $30.99 billion
Growth Rate CAGR of 7.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Drug Class, Route Of Administration, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, Eli Lilly and Company, Amgen Inc., Dr Reddy’s Laboratories, Innovent Biologics Inc., Bio-Thera Solutions, Celgene Corporation, Arcutis Biotherapeutics, LEO Pharma A/S, Sun Pharmaceutical Industries Ltd, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Biocon Ltd, Stiefel Laboratories Inc, Regeneron Pharmaceuticals, Sanofi S.A., GSK plc, Merck & Co. Inc., UCB S.A., Roche Holding AG, Evelo Biosciences Inc, Biogen Inc.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Chronic Plaque Psoriasis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Chronic Plaque Psoriasis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Chronic Plaque Psoriasis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Chronic Plaque Psoriasis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Adoption Of Biologic Therapies

4.2.2 Rising Use Of Targeted Small Molecule Drugs

4.2.3 Growing Focus On Personalized Dermatology Care

4.2.4 Expansion Of Oral Treatment Options

4.2.5 Enhanced Emphasis On Long-Term Disease Control

5. Chronic Plaque Psoriasis Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Dermatology Clinics

5.3 Specialty Skin Care Centers

5.4 Research Institutes

5.5 Specialty Pharmacies

6. Chronic Plaque Psoriasis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Chronic Plaque Psoriasis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Chronic Plaque Psoriasis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Chronic Plaque Psoriasis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Chronic Plaque Psoriasis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Chronic Plaque Psoriasis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Chronic Plaque Psoriasis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Chronic Plaque Psoriasis Market Segmentation

9.1. Global Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biologics, Small Molecule Drugs

9.2. Global Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injectable, Oral, Topical

9.3. Global Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

9.4. Global Chronic Plaque Psoriasis Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors (IL-12, IL-23, IL-17, IL-22), T-Cell Inhibitors

9.5. Global Chronic Plaque Psoriasis Market, Sub-Segmentation Of Small Molecule Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Phosphodiesterase 4 (PDE4) Inhibitors, Janus Kinase (JAK) Inhibitors, Retinoids

10. Chronic Plaque Psoriasis Market Regional And Country Analysis

10.1. Global Chronic Plaque Psoriasis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Chronic Plaque Psoriasis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Chronic Plaque Psoriasis Market

11.1. Asia-Pacific Chronic Plaque Psoriasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Chronic Plaque Psoriasis Market

12.1. China Chronic Plaque Psoriasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Chronic Plaque Psoriasis Market

13.1. India Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Chronic Plaque Psoriasis Market

14.1. Japan Chronic Plaque Psoriasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Chronic Plaque Psoriasis Market

15.1. Australia Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Chronic Plaque Psoriasis Market

16.1. Indonesia Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Chronic Plaque Psoriasis Market

17.1. South Korea Chronic Plaque Psoriasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Chronic Plaque Psoriasis Market

18.1. Taiwan Chronic Plaque Psoriasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Chronic Plaque Psoriasis Market

19.1. South East Asia Chronic Plaque Psoriasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Chronic Plaque Psoriasis Market

20.1. Western Europe Chronic Plaque Psoriasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Chronic Plaque Psoriasis Market

21.1. UK Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Chronic Plaque Psoriasis Market

22.1. Germany Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Chronic Plaque Psoriasis Market

23.1. France Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Chronic Plaque Psoriasis Market

24.1. Italy Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Chronic Plaque Psoriasis Market

25.1. Spain Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Chronic Plaque Psoriasis Market

26.1. Eastern Europe Chronic Plaque Psoriasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Chronic Plaque Psoriasis Market

27.1. Russia Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Chronic Plaque Psoriasis Market

28.1. North America Chronic Plaque Psoriasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Chronic Plaque Psoriasis Market

29.1. USA Chronic Plaque Psoriasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Chronic Plaque Psoriasis Market

30.1. Canada Chronic Plaque Psoriasis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Chronic Plaque Psoriasis Market

31.1. South America Chronic Plaque Psoriasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Chronic Plaque Psoriasis Market

32.1. Brazil Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Chronic Plaque Psoriasis Market

33.1. Middle East Chronic Plaque Psoriasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Chronic Plaque Psoriasis Market

34.1. Africa Chronic Plaque Psoriasis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Chronic Plaque Psoriasis Market Regulatory and Investment Landscape

36. Chronic Plaque Psoriasis Market Competitive Landscape And Company Profiles

36.1. Chronic Plaque Psoriasis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Chronic Plaque Psoriasis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Chronic Plaque Psoriasis Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Chronic Plaque Psoriasis Market Other Major And Innovative Companies

Eli Lilly and Company, Amgen Inc., Dr Reddy’s Laboratories, Innovent Biologics Inc., Bio-Thera Solutions, Celgene Corporation, Arcutis Biotherapeutics, LEO Pharma A/S, Sun Pharmaceutical Industries Ltd, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Biocon Ltd, Stiefel Laboratories Inc, Regeneron Pharmaceuticals, Sanofi S.A.

38. Global Chronic Plaque Psoriasis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Chronic Plaque Psoriasis Market

40. Chronic Plaque Psoriasis Market High Potential Countries, Segments and Strategies

40.1 Chronic Plaque Psoriasis Market In 2030 - Countries Offering Most New Opportunities

40.2 Chronic Plaque Psoriasis Market In 2030 - Segments Offering Most New Opportunities

40.3 Chronic Plaque Psoriasis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Chronic Plaque Psoriasis Market, Overview Of Key Products - Product Examples
  • Table 2: Global Chronic Plaque Psoriasis Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Chronic Plaque Psoriasis Market, Supply Chain Analysis
  • Table 4: Global Chronic Plaque Psoriasis Market, Major Raw Material Providers
  • Table 5: Global Chronic Plaque Psoriasis Market, Major Resource Providers
  • Table 6: Global Chronic Plaque Psoriasis Market, Major Manufacturers (Suppliers)
  • Table 7: Global Chronic Plaque Psoriasis Market, Major Distributors And Channel Partners
  • Table 8: Global Chronic Plaque Psoriasis Market, Key Technologies & Future Trends
  • Table 9: Global Chronic Plaque Psoriasis Market, Major Trends
  • Table 10: Global Chronic Plaque Psoriasis Market, Major End Users
  • Table 11: Global Chronic Plaque Psoriasis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Chronic Plaque Psoriasis Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Chronic Plaque Psoriasis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Chronic Plaque Psoriasis Market - TAM, US$ Billion, 2025
  • Table 15: Global Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Chronic Plaque Psoriasis Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Chronic Plaque Psoriasis Market, Sub-Segmentation Of Small Molecule Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Chronic Plaque Psoriasis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Chronic Plaque Psoriasis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Chronic Plaque Psoriasis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Chronic Plaque Psoriasis Market - Company Scoring Matrix
  • Table 96: Pfizer Inc. Financial Performance
  • Table 97: Johnson & Johnson Financial Performance
  • Table 98: AbbVie Inc. Financial Performance
  • Table 99: Bristol-Myers Squibb Company Financial Performance
  • Table 100: Novartis AG Financial Performance
  • Table 101: Global Chronic Plaque Psoriasis Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Chronic Plaque Psoriasis Market, Competitive Dashboard
  • Table 103: Global Chronic Plaque Psoriasis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Chronic Plaque Psoriasis Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 105: Global, Chronic Plaque Psoriasis Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 106: Global, Chronic Plaque Psoriasis Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Chronic Plaque Psoriasis Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Chronic Plaque Psoriasis Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Chronic Plaque Psoriasis Market, Supply Chain Analysis
  • Figure 4: Global Chronic Plaque Psoriasis Market, Major Raw Material Providers
  • Figure 5: Global Chronic Plaque Psoriasis Market, Major Resource Providers
  • Figure 6: Global Chronic Plaque Psoriasis Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Chronic Plaque Psoriasis Market, Major Distributors And Channel Partners
  • Figure 8: Global Chronic Plaque Psoriasis Market, Key Technologies & Future Trends
  • Figure 9: Global Chronic Plaque Psoriasis Market, Major Trends
  • Figure 10: Global Chronic Plaque Psoriasis Market, Major End Users
  • Figure 11: Global Chronic Plaque Psoriasis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Chronic Plaque Psoriasis Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Chronic Plaque Psoriasis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Chronic Plaque Psoriasis Market - TAM, US$ Billion, 2025
  • Figure 15: Global Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Chronic Plaque Psoriasis Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Chronic Plaque Psoriasis Market, Sub-Segmentation Of Small Molecule Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Chronic Plaque Psoriasis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Chronic Plaque Psoriasis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Chronic Plaque Psoriasis Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Chronic Plaque Psoriasis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Chronic Plaque Psoriasis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Chronic Plaque Psoriasis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Chronic Plaque Psoriasis Market - Company Scoring Matrix
  • Figure 96: Pfizer Inc. Financial Performance
  • Figure 97: Johnson & Johnson Financial Performance
  • Figure 98: AbbVie Inc. Financial Performance
  • Figure 99: Bristol-Myers Squibb Company Financial Performance
  • Figure 100: Novartis AG Financial Performance
  • Figure 101: Global Chronic Plaque Psoriasis Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Chronic Plaque Psoriasis Market, Competitive Dashboard
  • Figure 103: Global Chronic Plaque Psoriasis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Chronic Plaque Psoriasis Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 105: Global, Chronic Plaque Psoriasis Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 106: Global, Chronic Plaque Psoriasis Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Psoriasis Market Report 2026 - Global Outlook – By Drug class (Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor), By Drug Types (Small molecules, Biologics  ), By Disease Indica...

Chronic Spontaneous Urticaria Market Report 2026 - Global Outlook – By Treatment (Medication, Phototherapy, Other Treatments), By Route Of Administration (Oral, Topical, Parenteral, Other Routes Of Administrations), By D...

Veterinary Dermatology Drugs Market Report 2026 - Global Outlook – By Product Type (Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs), By Animal Type (Companion Animal, Livestock Animal), By Drug Indication (Pa...

Rheumatology Therapeutics Market Report 2026 - Global Outlook – By Drug Class (Disease Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Other Drugs Classes), By Dist...

Dermatitis Market Report 2026 - Global Outlook – By Drug Class (Corticosteroids, Emollients Or Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors), By Distribution...

Pigmentation Disorders Treatment Market Report 2026 - Global Outlook – By Treatment Type (Topical Treatment, Dermabrasion, Chemical Peels, Laser Treatment, Phototherapy, Other Treatment Types), By Drugs (Calcineurin Inhi...

Rosacea Market Report 2026 - Global Outlook – By Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea), By Drug Class (Antibiotics, Alpha Agonists, Retinoid, Corticosteroids, ...

Dermatology Drugs Global Market Report 2022 – By Type (Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By R...

Frequently Asked Questions

The Chronic Plaque Psoriasis market was valued at $22.26 billion in 2025, increased to $23.83 billion in 2026, and is projected to reach $30.99 billion by 2030.

The global Chronic Plaque Psoriasis market is expected to grow at a CAGR of 6.8% from 2026 to 2035 to reach $30.99 billion by 2035.

Some Key Players in the Chronic Plaque Psoriasis market Include, Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bristol‑Myers Squibb Company, Novartis AG, Eli Lilly and Company, Amgen Inc., Dr Reddy’s Laboratories, Innovent Biologics Inc., Bio‑Thera Solutions, Celgene Corporation, Arcutis Biotherapeutics, LEO Pharma A/S, Sun Pharmaceutical Industries Ltd, AstraZeneca plc, Takeda Pharmaceutical Company Limited, Biocon Ltd, Stiefel Laboratories Inc, Regeneron Pharmaceuticals, Sanofi S.A., GSK plc, Merck & Co. Inc., UCB S.A., Roche Holding AG, Evelo Biosciences Inc, Biogen Inc. .

Major trend in this market includes: Advancements In IL-17A And IL-17F Inhibitor Therapies For Plaque Psoriasis Treatment. For further insights on this market. request a sample here

North America was the largest region in the chronic plaque psoriasis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic plaque psoriasis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us